Cor Vasa 2009, 51(2):128-130 | DOI: 10.33678/cor.2009.031
Brno Registry - Drug therapy after myocardial infarction
- Interní kardiologická klinika, Fakultní nemocnice Brno a Lékařská fakulta Masarykovy univerzity, Brno, Česká republika
The authors present a review of antiplatelet therapy taken by patients discharged from Brno University Hospital over the years 2005-2008. Data of a total of 2,005 cases of acute myocardial infarction occurring in 1,858 patients were analyzed; 88 patients died while hospitalized, 1,917 patients were discharged to receive home care or care in another health-care facility. Upon discharge, 89.15% of patients were on ACE inhibitors or angiotensin II receptor blockers, 89.51% on beta-blockers, 93.74% on antiplatelet agents, and 89.50% of patients were taking a lipid-lowering drug. Three in four of these patients were on all four drug classes, with another 20% of patients taking at least three basic classes of drugs as recommended.
Keywords: Myocardial infarction; ACE inhibitor; Beta-blocker; Antiplatelet therapy; Statin
Published: February 1, 2009 Show citation
References
- Šimon J, et al. Epidemiologie a prevence ischemické choroby srdeční. 1. vyd. Praha: Grada Publishing, 2001:264.
- Špinar J, Vítovec J, et al. Ischemická choroba srdeční. 1. vyd. Praha: Grada Publishing, 2003:364.
- Wodd DA. Euro Heart Survey Programme - Euroapsire III, ústní sdělení, www.escardio.org
- Hanuš P, Faltus V, Grunfeldová H, et al. Léčba akutního infarktu myokardu, guidelines a klinická praxe podle dat z pilotního projektu registru infarktu myokardu z let 2003-2007. Cor Vasa 2008;50: (Suppl CV 4):159.
- Morrow DA, Scirica BM, Karwatowska, Prokopzuck E, et al. Effects of Ranolazine on Recurent Cardiovascular Events in patients With Non-ST Elevation Acute Coronary Syndromes. The MERLIN-TIMI 36 Randomized Trial. JAMA 2007;297:1775-83.
Go to original source... 
Go to PubMed... - Vítovec J, Špinar J. Klinické studie - Triton, Corona, Enhance. Kardiol Rev 2008;10:37-41.
- Špinar J, Vítovec J. Studie TRITON-TIMI 38. Remedia 2008;18:172-5.
- McMurray JJV, Pitt B, Latini R, et al. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart Fail 2008; 1:17-24. Go to original source... Go to PubMed...
- Souček M, Fráňa P, Plachý M, Řiháček I. Aliskiren. Remedia 2008;18: 272-86.